Agape ATP Corporation (NASDAQ:ATPC – Get Free Report) saw a large drop in short interest in June. As of June 15th, there was short interest totaling 18,792 shares, a drop of 94.0% from the May 31st total of 314,161 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average daily volume of 804,194 shares, the short-interest ratio is currently 0.0 days.
Institutional Inflows and Outflows
A hedge fund recently raised its position in Agape ATP stock. Citadel Advisors LLC boosted its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 0.01% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on ATPC. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. Wall Street Zen downgraded shares of Agape ATP from a “hold” rating to a “sell” rating in a research note on Sunday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Agape ATP presently has an average rating of “Sell”.
Agape ATP Stock Down 4.8%
Shares of Agape ATP stock traded down $0.15 on Thursday, reaching $3.00. 89,718 shares of the stock were exchanged, compared to its average volume of 7,055,344. Agape ATP has a twelve month low of $1.72 and a twelve month high of $75.25. The firm has a market capitalization of $3 million, a price-to-earnings ratio of -2.26 and a beta of 0.08. The business has a 50 day moving average price of $2.89 and a two-hundred day moving average price of $4.28.
Agape ATP (NASDAQ:ATPC – Get Free Report) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.The business had revenue of $0.27 million during the quarter.
Agape ATP Company Profile
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Featured Articles
- Five stocks we like better than Agape ATP
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
